
[Federal Register Volume 84, Number 48 (Tuesday, March 12, 2019)]
[Notices]
[Pages 8875-8876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-04431]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-D-1113]


Data Integrity and Compliance With Drug Current Good 
Manufacturing Process: Questions and Answers; Guidance for Industry; 
Availability; Correction

AGENCY: Food and Drug Administration, HHS

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a notice 
entitled ``Data Integrity and Compliance With Drug CGMP: Questions and 
Answers; Guidance for Industry; Availability'' that appeared in the 
Federal Register of December 13, 2018. The document announced the 
availability of a guidance for industry. The document was published 
with the incorrect docket number. This document corrects that error. 
Previously submitted comments will be transferred to the correct docket 
number.

FOR FURTHER INFORMATION CONTACT: Karen Takahashi, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 75, Rm. 6686,

[[Page 8876]]

Silver Spring, MD 20993-0002, 301-796-3191.

SUPPLEMENTARY INFORMATION: In the Federal Register of Thursday, 
December 13, 2018 (83 FR 64132), in FR Doc. 2018-26957, the following 
correction is made:
    On page 64132, in the first column, in the header of the document, 
``[Docket No. FDA-2018-D-3984]'' is corrected to read ``[Docket No. 
FDA-2016-D-1113].''

    Dated: March 6, 2019.
Lowell J. Schiller,
Acting Associate Commissioner for Policy.
[FR Doc. 2019-04431 Filed 3-11-19; 8:45 am]
 BILLING CODE 4164-01-P


